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Porter AM, Klinge CM, Gobin AS. Covalently grafted VEGF165 in hydrogel models upregulates the cellular pathways associated with angiogenesis. Am J Physiol Cell Physiol 301: C1086 -C1092, 2011. First published July 27, 2011; doi:10.1152/ajpcell.00090.2011.-Angiogenesis is an important biological response known to be involved in many physiological and pathophysiological situations. Cellular responses involved in the formation of new blood vessels, such as increases in endothelial cell proliferation, cell migration, and the survival of apoptosis-inducing events, have been associated with vascular endothelial growth factor isoform 165 (VEGF 165). Current research in the areas of bioengineering and biomedical science has focused on developing polyethylene glycol (PEG)-based systems capable of initiating and sustaining angiogenesis in vitro. However, a thorough understanding of how endothelial cells respond at the molecular level to VEGF165 incorporated into these systems has not yet been established in the literature. The goal of the current study was to compare the upregulation of key intracellular proteins involved in angiogenesis in human umbilical vein endothelial cells (HUVEC) and human microvascular endothelial cells (HMEC) seeded on PEG hydrogels containing grafted VEGF165 and adhesion peptides ArgGly-Asp-Ser (RGDS). Our data suggest that the covalent incorporation of VEGF165 into PEG hydrogels encourages the upregulation of signaling proteins responsible for increases in endothelial cell proliferation, cell migration, and the survival after apoptosis-inducing events.
human microvascular endothelial cells; human umbilical vein endothelial cells; hydrogel; biomimetics RESEARCHERS in the field of biomedical science are faced with characterizing cellular processes on both the cellular and molecular levels. Materials such as hyaluronic acid (HA), Matrigel, and polyethylene glycol (PEG) hydrogels have been utilized as biomimetic materials for studying angiogenesis in vitro (5, 18, 22, 23) . It has been recently shown that the physiological processes associated with angiogenesis can be analyzed using PEG-based hydrogels in cellular-scale experiments (17, 23) . However, investigation of molecular-level endothelial cell responses to pro-angiogenic growth factors in PEG hydrogels is still unknown.
There is a plethora of pro-angiogenic cytokines involved throughout the process of angiogenesis (9, 12) . The most well studied of these substances, namely vascular endothelial growth factor (VEGF), fibroblast growth factor, endothelin-1, and angiopoietin-1, enter into the process of angiogenesis at different stages (7, 22, 24, 26) . VEGF has been shown to be one the most potent and bioactive of the growth factors in initiating angiogenesis by increasing proliferation, inducing extracellular matrix (ECM) degradation to further cell migration and subsequent lumen formation, and the survival of events that normally induce programmed cell death caused by oxidative stress throughout the process (3, 8, 16, 28) . Another key component of angiogenesis is the attachment of endothelial cells to the ECM. Arg-Gly-Asp (RGD)-based amino acid sequences in the ECM are presented to the integrins on the cell membrane, creating high affinity focal adhesions (6, 20) . As more cells attach to the newly remodeled ECM, cell-cell junctions are formed and cross talk between the cells ensues (25) . Thus, without proper attachment to the ECM, adequate cellular responses to relevant biological signals would not occur. Angiogenesis is also a fundamental process in tumorigenesis, wound healing, and embryological development, further underpinning the scientific importance of understanding how endothelial cells respond to physiological stimuli (2, 13, 14) .
PEG hydrogels are effective for studying angiogenesis because they are resistant to protein adsorption and thus, can be tailored to present selected growth factors and adhesion sequences to the cell surface to model in vivo conditions (10, 11, 17, 23) . A backbone of 6,000 Da PEG diacrylate (PEGDA 6K), was photopolymerized to form a polymer network capable of supporting endothelial cells (23) . It includes the adhesion sequence RGDS (Arg-Gly-Asp-Ser) and the pro-angiogenic cytokine VEGF 165 by covalently tethering them into the hydrogel via PEG linker chains. Previous studies indicate that covalent incorporation of relevant biological signals such as VEGF 165 and RGDS directly into the hydrogels does not significantly affect its bioavailability or bioactivity (17, 23) . However, studies into the specific actions of hydrogel-grafted VEGF 165 interacting with VEGF receptors (VEGFR) at the molecular level have not yet been studied. A more complete understanding of these intracellular responses could render avenues for innovation in the fields of medicine, drug design, and delivery, and tissue engineering.
Our current research has been devoted to how intracellular protein signaling is effected by cellular interactions with hydrogels. Our hypothesis that covalently grafting VEGF 165 into a hydrogel increases the upregulation of key proteins involved in angiogenic signaling is supported by our findings. We have demonstrated that the process of covalently incorporating VEGF into PEG hydrogels does not decrease its efficacy in inducing the aforementioned processes. We implemented our techniques to focus on proteins such as extracellular regulated kinase (ERK), Akt, and c-Src. These intracellular proteins have been reported to be phosphorylated subsequent to VEGF 165 binding to VEGFR-2, therefore, increasing cell proliferation, the survival of apoptosis-inducing events, and cell migration, respectively (15, 19, 27) (Fig. 1) . To illustrate the differences in VEGF 165 -induced angiogenic effects on cells from both small and large diameter vessels, experimentation was carried out on human microvascular endothelial cells (HMEC) and human umbilical vein endothelial cells (HUVEC), respectively.
MATERIALS AND METHODS
All reagents and chemicals were obtained from Fisher Scientific (Waltham, MA) unless otherwise stated.
Synthesis of Polyethlene Glycolated VEGF165 and RGDS Adhesion Ligand
PEG-conjugated VEGF165 (5:1 PEG-NHS:VEGF) and RGDS (1:1 PEG-NHS:RDGS) adhesion peptide were synthesized by dissolving VEGF165 (Promokine; Heidelberg, Germany) or RDGS (American Peptide; Sunnyvale, CA) peptide in sodium bicarbonate buffer (NaHCO 3 50 mM, pH 8.5) at 25°C. PEG N-hydroxysuccinimide (PEG-NHS, 3,400 Da; Nektar; Huntsville, AL) was then dissolved in NaHCO 3 buffer at room temperature. PEG-NHS solution was then added dropwise to the VEGF 165 or RGDS solution and mixed on an orbital shaker for 2 h at 25°C. Afterwards, the reacted solution was dialyzed (MWCO 3,400 Da) overnight. The resulting sample was frozen at Ϫ80°C and lyophilized.
PEG Hydrogel Formation
PEGDA 6K was synthesized via combining PEG 6K Da with triethyl amine and acryloyl chloride at a 1:4:2 molar ratio in a round bottom flask under argon overnight. The next day, the mixture was added to a separatory funnel along with 16 ml of 2 M potassium carbonate (K2CO3) and allowed to separate overnight while protected from light. The bottom phase of the solution was removed and dried with MgSO 4 and filtered. The resulting PEG solution was then precipitated in cold ethyl ether, filtered, and dried via vacuum for 2 days.
Hydrogels were formed by a photopolymerization reaction. PEGDA6k (0.1 g/ml in HEPES buffer, pH 7.4; 10 mM), PEG-RGDS adhesion peptide (2.8 mol/ml), and PEG-VEGF 165 (50 ng/ml) were combined. The solution was then filter sterilized and protected from light. Acetophenone photoinitiator (10 l) (600 mg/ml in N-vinyl pyrollidinone) was then added. Prepolymer solution was then transferred to an appropriate experimental container and exposed to UV light (365 nm, 10 mW/cm 2 ) for 1-2 min to form solid hydrogels. Hydrogels are stored in PBS or cell culture medium to prevent desiccation before use.
Cell Culture
HUVEC and HMEC were purchased from Cascade Biologics (Portland, OR) and cultured in endothelial cell growth medium 200 and 131, respectively, as prescribed by Cascade Biologics. Endothelial growth medium' contained antibiotic cocktail of penicillin (10,000 IU/ml), streptomycin (10,000 g/ml), and glutamine (29.2 mg/ml) and was supplemented with 2% (vol/vol) fetal bovine serum; 1 g/ml hydrocortisone; 10 ng/ml human epidermal growth factor; 3 ng/ml basic fibroblast growth factor (bFGF); and 10 g/ml heparin. Cells from passages 2-6 were used in reported studies.
Assessment of Protein Expression and Phosphorylation via ELISA
The upregulation of key intracellular proteins involved in angiogenesis was measured via ELISA. The amount of phosphorylated protein was compared with the amount of total unphosphorylated protein to determine the extent of protein activation upon VEGF stimulation. The proteins of interest, ERK, Akt and c-Src, were measured to assess cell proliferation, the survival of apoptosis-inducing events, and cell migration, respectively. In all studies, hydrogels were photopolymerized in 96-well plates and allowed to swell. For both the ERK and Akt measurements, HUVEC and HMEC cells were plated at 80% confluency and allowed to attach to the hydrogel surface overnight. For the migration studies, the endothelial cells were seeded at 20% confluency to allow enough space for migration to occur.
Intracellular protein expression in cell proliferation, cell migration, and apoptosis studies was determined using a colorimetric fast activated cell-based ELISA (FACE) kit (Active Motif; Carlsbad, CA). Primary (1°) antibodies specific to ERK/P-ERK, c-Src/P-c-Src, and Akt/P-Akt were provided in each ELISA kit. Fixed samples were washed three times with a washing buffer (1 ϫ PBS containing 0.1% TWEEN) for 5 min each at 25°C and then quenched with a quenching buffer (washing buffer containing 1% hydrogen peroxide and 0.1% azide) for 20 min at 25°C to inactivate cells' endogenous peroxidase activity. Cells were then washed two times with washing buffer for 5 min each and blocked with antibody blocking buffer for 1 h at 25°C. A 1°antibody was diluted in antibody dilution buffer (1:500 dilution for total protein groups; 1:250 dilution for phosphorylated protein groups), and 100 l of the diluted antibody was added for a subsequent overnight incubation at 4°C. The next day, cells were washed with washing buffer three times for 5 min each, after which 100 l of diluted secondary (2°) antibody (horseradish peroxidase-conjugated; 1:2,000 dilution) were added to all of the groups for 1 h at 25°C. Cells were then washed three times with wash buffer for 5 min each and then an additional two times with 1 ϫ PBS for 5 min each. Developing solution (100 l) was then added to each of the wells for 20 min in the dark at 25°C, followed by the addition of 100 l of stop solution. The resultant solution absorbance was then read at 450 nm on an UV/Vis spectrometer (BioTek; Winooski, VT).
Quantification of VEGF-induced mitogen-activated protein kinase activation. Studies were performed in parallel to assess total ERK and phosphorylated ERK present. At t ϭ 0 h, the medium was replaced with new experimental medium: 1) VEGF suspended in the medium (50 ng/ml) or 2) VEGF covalently incorporated into the hydrogel itself (50 ng/ml). The medium for negative control groups contained only 2% FBS for the duration of the study (No VEGF).The hydrogels were incubated for 48 h. After which, cells were fixed with 4% formaldehyde solution.
Quantification of VEGF-induced Akt activation. Levels of phosphorylated Akt were measured to determine relative levels of endothelial cell survival after apoptosis induction in VEGF-treated or VEGF-free conditions. Once the cells were attached, they were exposed to 50 ng/ml tumor necrosis factor-␣-related apoptosis inducing ligand (TRAIL; Biosource; Camarillo, CA) in 2% FBS only containing medium for 6 h at 37°C to initiate apoptosis. The negative control group (No Induction) contained only 2% FBS for the duration of the study. The positive control group (Apoptosis Induced, No VEGF) was exposed to TRAIL for 6 h and immediately fixed with 4% formaldehyde. For the experimental groups, the apoptosis-inducing medium was aspirated and VEGF was administered either in the medium or covalently grafted into the hydrogel (50 ng/ml) for a subsequent 24-h rescue period at 37°C. At the end of the rescue period, the cells were fixed with 4% formaldehyde solution.
Quantification of c-Src activity. Endothelial cell migration was assessed by measuring levels of phosphorylated c-Src in HUVEC and HMEC under VEGF-treated or VEGF-free conditions. Studies were performed in parallel to assess both phosphorylated c-Src as well as the total c-Src present. Once cells were attached, the cell medium was aspirated and new experimental medium (2% FBS, vol/vol) was added. Experimental groups were exposed to VEGF either via the medium (50 ng/ml) or via covalent incorporation into the hydrogel itself (50 ng/ml). The medium for negative control groups contained only 2% FBS for the duration of the study. Once medium was changed, the plates were incubated at 37°C for 48 h. After which, the cells were fixed with 4% formaldehyde solution.
Statistical Analysis
Results are represented as averages with standard deviations. All studies were performed in triplicate and statistically analyzed via one-way ANOVA with Tukey ad hoc testing. Results with P Ͻ 0.05 were considered significantly different.
RESULTS

Cell Proliferation: Assessment of ERK Expression and Activation
VEGF has been shown to significantly increase proliferation of several endothelial cell types (1, 4, 29) . When incorporated into biomimetic hydrogels, it was observed that cell proliferation can be modulated due to the presentation of VEGF. ELISA studies were performed to compare the amount of expressed (Total ERK) and activated (phosphorylated or P-ERK) ERK in HUVEC and HMEC adhered on hydrogels with VEGF and RGDS (Fig. 2) . It was observed that total amount of ERK expressed was not significantly different if the hUVECs were on hydrogels without VEGF, if VEGF was suspended in the media alone, or VEGF grafted in the hydrogel (Fig. 2A) . However, the amount of activated ERK (P-ERK) was significantly increased in cells on hydrogels with VEGF compared with no growth factor present (P ϭ 0.0001). In addition, it was observed that VEGF in the media alone had only an intermediate level of activation (P Ͼ 0.05).
Similar proliferative behavior was seen with the HMEC when on the biomimetic hydrogels (Fig. 2B) . It was observed that the total amount of ERK expressed was not different among groups in which VEGF was presented to the cells differently; none, soluble in media or grafted into hydrogel. However, a robust activation response was seen when VEGF was administered. The amount of phosphorylated ERK was significantly greater than when no VEGF was present (P ϭ 0.0076) or even when in the media alone (P ϭ 0.008). HMECs were found to be responsive to VEGF, as seen in the significant increase in activation when presented as a soluble factor in the media versus none (P ϭ 0.017).
Apoptosis Recovery: Assessment of Akt Expression and Activation
VEGF has been shown to effectively reverse the apoptotic process and initiate recovery in endothelial cells via upregulation of Akt. Hence, to investigate the cellular response on our hydrogel system in an apoptotic environment, the cells were stimulated with TRAIL (21) . After a 6-h stimulation with TRAIL, Akt expression and activation was measured after presentation of VEGF in the media alone or from the hydrogel surface for 24 h (Fig. 3) . When investigating the HUVEC response (Fig. 3A) , it was first observed that the total amount of Akt expressed (Total Akt) was not significantly different among all groups. In addition, it was seen that when the HUVEC were induced but not rescued with VEGF the amount of activated Akt (P-Akt) did not change. However, when VEGF was presented in the media, P-Akt increased significantly (P ϭ 0.047). Moreover, there was a robust level of activation when VEGF was presented via the hydrogel over no VEGF (P ϭ 0.002) or VEGF in the media alone (P ϭ 0.002).
Total Akt amount expressed was not different among groups when investigating HMEC (Fig. 3B) . As with the HUVEC, HMEC activation did not increase when apoptotically induced but not rescued. Also in similar fashion, HMEC activated more Akt when VEGF was presented (Fig. 3B) . When VEGF was in the media, it was observed that there was a significant increase in activation compared with no VEGF present (P ϭ 0.004). There was even more increase in phosphorylation when the VEGF was conjugated within the system (P ϭ 0.012).
Cell Migration: Assessment of c-Src Kinase Expression and Activation
Cell migration is a very complex process that can be assessed in many ways, at both the cell-size scale and the molecular levels. c-Src is a protein kinase involved in cell migration and was chosen to assess the molecular activation (26) . Figure 4 depicts the levels of expressed (Total c-Src) and Fig. 3 . Total Akt and phosphorylated Akt (P-Akt) in HUVEC (A) and HMEC (B). Total Akt expression was not significantly different among experimental groups. However, there was significant increase in P-Akt expression when VEGF was presented in the media or via the hydrogels to the cells. *P Ͻ 0.05, #P Ͻ 0.01.
Fig. 2. Total ERK and phosphorylated ERK (P-ERK) Expression in human umbilical vein endothelial cells (HUVEC, A) and human microvascular cells (HMEC, B)
. Total ERK expression was not significantly different among experimental groups. However, there was significant increase in the amount phosphorylated when VEGF was presented to the cells either in the media or via the hydrogel. *P Ͻ 0.05, #P Ͻ 0.01, $P Ͻ 0.001. There was no significant increase in the level of P-ERK in HUVEC treated with VEGF in the media, suggesting only an intermediate increase in ERK activation. activated (P-c-Src) c-Src in HUVEC and HMEC. The total amount of expressed c-Src was the same among all groups. Levels of activated c-Src in HUVEC were observed to be significantly higher in VEGF-treated groups than when no VEGF was present ( Fig. 4A ; P Ͻ 0.05). Covalently grafting VEGF into the hydrogel matrix was observed to have nearly doubled the activation of c-Src compared with VEGF that had simply been suspended in the medium, though this was not found to be statistically different (P ϭ 0.094).
HMEC response to VEGF-induced cell migration showed similar results to those of HUVEC, with a more potent response to the stimulus (Fig. 4B) . As was the case in HUVEC studies, levels of total c-Src were not statistically different in each of the groups tested in HMEC. Covalently grafted VEGF and medium-suspended VEGF groups each showed a statistically significant increase in c-Src activation over control levels (P Ͻ 0.0001 and P ϭ 0.002, respectively), suggesting VEGF was responsible for phosphorylation. Levels of c-Src activation in grafted VEGF group were also significantly higher than those observed in medium-suspended VEGF groups (P ϭ 0.039).
DISCUSSION
The overarching goal of our work is to develop a novel biomimetic model capable of assessing angiogenesis in vitro.
A biomimetic system is capable of recapitulating various aspects of the physiological environment, with precise control over identity, concentration, and spatial organization of the molecular components presented to the cells (5, 6, 21, 22) . To develop such a system to investigate angiogenesis, we first investigated a key growth factor involved in the initiation of blood vessel growth: VEGF. The growth factor and other molecular signals are covalently incorporated into the biomimetic system via a PEG chain linker (4, 20) . This provides the control described above as well as developing a system that is only responsive to the cells within it and not thermodynamically driven reactions.
Angiogenesis involves many orchestrated steps, including presentation with various growth factors, extracellular matrix remodeling, and cellular communication with the ECM and other cells. Within this biomimetic model, the current goal of the presented work was to assess the cellular response at the molecular level. We have already shown that VEGF incorporated into PEG hydrogels is effective in eliciting stimulatory responses in endothelial cells (17, 23) . However, evaluation at the molecular level had not been completed to date. Information obtained at this level is necessary to better understand the inner workings of the VEGF-VEGF receptor interaction with regards to our biomimetic system and to provide a means of comparing previously reported two-dimensional studies to future three-dimensional, degradable systems. The focus of the presented work includes three biological processes that have been shown to be upregulated via VEGF stimulation during angiogenesis: cell proliferation (ERK), cell migration (c-Src), and the survival of pro-apoptotic cellular microenvironments (Akt). In addition, we compare the responses of both venous cells (HUVEC) and microvascular cells (HMEC) within the system.
We have previously shown that the modification of VEGF and inclusion of the resulting complex into a PEG hydrogel does not affect its ability to interact with the VEGF receptor on the membranes of endothelial cells (23) . In these studies, levels of activated ERK were greater in groups subjected to VEGF suspended in the cell culture medium or stimulated with VEGF that was covalently incorporated into the hydrogel than those observed in the VEGF-free control (Fig. 2 ). In the HMEC proliferation studies, this difference was significant, with a 10-fold greater activation in cells on hydrogels with VEGF and nearly 4-fold activation when VEGF was in the media only. In addition, there was a 3-fold increase in activation in cells on hydrogels with VEGF than cells exposed to soluble VEGF only. HUVEC results were similar in trend but not as pronounced as the HMEC.
To assess the survival of endothelial cells in an apoptotic environment, expression and activation of Akt was examined. Apoptosis was induced via administration of TRAIL (50 ng/ ml) in the cell medium for 6 h, which was followed by a subsequent 24-h incubation period with VEGF either suspended in the medium or covalently grafted within the hydrogel. Addition of VEGF into the media increased activation of Akt in both cell types; however, only the HMEC had a significant increase (Fig. 3) . When VEGF was presented via the hydrogel surface, there was significant increase in the amount of phosphorylation of Akt for both cell types over when VEGF was not presented, in which HUVEC appeared to have a more robust response in Akt activation than the HMEC. Molecular assessment of phosphorylated c-Src activity, a protein known to be upregulated by VEGF during cell migration in endothelial cells, is represented in Fig. 4 . Migration studies were conducted in the presence of an anti-proliferative fungal toxin mitomycin C (0.5 g/ml), which allows us to examine only the motogenic (migratory) responses to the presented VEGF. Phosphorylated c-Src levels in both the medium-suspended VEGF group and covalently grafted group were statistically greater than the VEGF-free control group in both HUVEC and HMEC. Once again, it was observed that VEGF, at 50 ng/ml, has a more robust stimulatory effect on HMEC than HUVEC.
Biomimetic PEG-based hydrogels will provide new tools and insights for enhancing physiological understanding, as opportunities to assess cellular events with better control of the cellular microenvironment may allow for decreased variability that is essential in measuring true cell behavior. For example, covalent immobilization of the growth factor into the hydrogel allowed us to assess multiple processes in multiple cell types that are involved in angiogenesis. Specifically, it is believed that the observed increases in molecular activation are due to the covalently grafted VEGF presenting a more stable and continuous stimulus to the VEGFR than VEGF suspended in the medium. In addition, it was observed that cell origin can also present a different degree of response to a single stimulus while at the same time showing a similar trend; use of microvascular endothelial cells are more physiologically relevant in the study of angiogenesis. Hence, the model system developed will provide a better mimic of the natural physiological environment.
Though VEGF is key in the initial steps of growth, we are able to look at time periods past initiation and into time intervals that may be pertinent for therapies. Such models can be helpful in determining therapeutic potential of immobilized biomolecules, a better understanding of certain pathologies, or further strengthening the basic knowledge of the field of vascular biology. These data show that our model is capable of assessing physiological events that have traditionally been difficult to study. Future studies will include more complex layers to better mimic the native cellular microenvironment.
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